A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma

A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma - A late phase II study to establish standard treatment for advanced neuroblastoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001044

Enrollment

Registered

2008-02-20

Start date

2007-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroblastoma

Interventions

Chemotherapy, surgery and radiotherapy for high-risk neuroblastoma patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: High-risk neuroblastoma patients aged between 1 to 18 years old

Exclusion criteria

Exclusion criteria: Active double cancer, pregnant or possiblly pregnant women and those during breast feeding, patients with psychologic disease or symptoms who have difficulty in receiving protocol treatment, patients with disease that may interfere with the protocol treatment

Design outcomes

Primary

Measure	Time frame
3-year progression free survival rate	—

Secondary

Measure	Time frame
3-year overall survival rate, the incidence of adverse events	—

Countries

Japan

Contacts

Public ContactMasa-aki Kumagai

National Center for Child Health and Development Division of Hematology

kumagai-ma@ncchd.go.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026